Data on outpatient antibiotic use were collected from 34 countries using the ATC/DDD methodology. Methods: For theperiod1997–2003, dataonoutpatient useof systemicantibiotics aggregatedat the levelof theactivesubstancewerecollectedandexpressed inDDD(WHO,version2004)per1000 inhabitantsperday (DID).Outpatient antibiotic (ATCJ01)use in 25Europeancountries, able todeliver validdata,wasanalysed. Results: Total outpatient antibiotic use in 2003 varied by a factor of 3 between the country with the highest (31.4DID inGreece) and thecountrywith the lowest (9.8DID in theNetherlands) use.General usepatterns in individual countries as well as trends during the period 1997–2003 are described in this paper, while major antibiotic classes (penicillins, cep...
Purpose: The ESAC project (European Study on Antibiotic Consumption) aims to collect antibiotic-use ...
OBJECTIVES: This article introduces a series of articles on antibiotic consumption in the community ...
Objectives: To assess the total systemic antiviral use in Europe and to identify the antiviral subst...
BACKGROUND: Data on more than a decade of outpatient macrolide, lincosamide and streptogramin (MLS) ...
Background: Data on outpatient penicillin use in Europe were collected from 25 countries withi
Background: Data on outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe were col...
OBJECTIVES: To describe total outpatient systemic antibiotic use in Europe from 1997 to 2009 and to ...
Objectives: To assess the proportion of parenteral treatment of the total outpatient antibiotic use ...
Background: Data on more than a decade of outpatient macrolide, lincosamide and streptogramin (MLS) ...
Objectives: To collect reliable, comparable and publicly available data on hospital use of antibioti...
Objectives: To describe total outpatient systemic antibiotic use in Europe from 1997 to 2009 and to ...
Objectives: To collect reliable, comparable and publicly available data on hospital use of antibioti...
†These authors contributed equally to this work. Background: Data on 13 years of outpatient cephalos...
The European Surveillance of Antimicrobial Consumption (ESAC) project collects data on antibacterial...
Monitoring the use of antibiotics is relevant due to the public health impact of microbial resistanc...
Purpose: The ESAC project (European Study on Antibiotic Consumption) aims to collect antibiotic-use ...
OBJECTIVES: This article introduces a series of articles on antibiotic consumption in the community ...
Objectives: To assess the total systemic antiviral use in Europe and to identify the antiviral subst...
BACKGROUND: Data on more than a decade of outpatient macrolide, lincosamide and streptogramin (MLS) ...
Background: Data on outpatient penicillin use in Europe were collected from 25 countries withi
Background: Data on outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe were col...
OBJECTIVES: To describe total outpatient systemic antibiotic use in Europe from 1997 to 2009 and to ...
Objectives: To assess the proportion of parenteral treatment of the total outpatient antibiotic use ...
Background: Data on more than a decade of outpatient macrolide, lincosamide and streptogramin (MLS) ...
Objectives: To collect reliable, comparable and publicly available data on hospital use of antibioti...
Objectives: To describe total outpatient systemic antibiotic use in Europe from 1997 to 2009 and to ...
Objectives: To collect reliable, comparable and publicly available data on hospital use of antibioti...
†These authors contributed equally to this work. Background: Data on 13 years of outpatient cephalos...
The European Surveillance of Antimicrobial Consumption (ESAC) project collects data on antibacterial...
Monitoring the use of antibiotics is relevant due to the public health impact of microbial resistanc...
Purpose: The ESAC project (European Study on Antibiotic Consumption) aims to collect antibiotic-use ...
OBJECTIVES: This article introduces a series of articles on antibiotic consumption in the community ...
Objectives: To assess the total systemic antiviral use in Europe and to identify the antiviral subst...